Resource Library
Featured Content
CNN’s John King interviews Color CEO about COVID-19 testing
“Making testing accessible is the context for our work with the city of San Francisco, working with local communities to set up programs so that tests can actually make it to the people who need it the most.”
COVID-19 testing to keep employees safe
CNBC highlights how Color’s “digitally streamlined” COVID-19 testing program is helping Verve Therapeutics and a large group of biotechnology companies keep their employees as safe as possible.
Color announces $75 million funding round
Fortune Exclusive details $75 million funding round led by T. Rowe Funds and Viking Global Investors.
Mobilizing Color’s Infrastructure in Response to the COVID-19 Crisis
CEO Othman Laraki discusses mobilizing the company to contribute its clinical testing infrastructure and services to support the emergency response.
NIH and Color partner on All of Us Research Program
As one of the All of Us Clinical Validation Laboratories, Color is responsible for the return of genomic results for the All of Us Research Program, which aims to recruit one million participants.
The Population Genomics Platform Playbook
A step-by-step guide outlining the core architectural elements required to implement a successful population genomics program.
To Get Back to Work, Companies Seek Coronavirus Tests for Workers
“The core tool we have to work with right now is direct covid testing,” said Othman Laraki, CEO of genetic-testing company Color, which is currently managing a testing site for San Francisco first responders as well as other essential city employees.
TechCrunch: Color receives FDA authorization for speedier COVID-19 test tech
Color has received an EUA from the FDA for a COVID-19 testing method that is as accurate as current tests, is about 50% faster and has different supply requirements.
Color to Collaborate with Sanford Health, Expand NorthShore Partnership
Color announces partnership with rural health system Sanford Health on its Imagenetics program, and expands its partnership with NorthShore University Health System.
Color and Jefferson Health
Jefferson Health CEO Stephen Klasko and EVP of Oncology Services/SKCC Director Karen Knudsen talk about the benefits of offering Color to its employees.
Color on NBC’s TODAY
Abby O’Connell, an operating room nurse at Jefferson Health, spoke with NBC TODAY’s Al Roker and Natalie Morales about how Color’s clinical genetic testing services “saved her life.”
Color’s Alicia Zhou @ TEDx: Dispelling Genetic Myths
Alicia talks about the value of knowing your genetic makeup and how that information allows you to become the driver of your health vs. simply being a passenger.
Color CEO Othman Laraki @ Fortune Brainstorm Health
Color’s CEO discusses how the healthcare industry doesn’t necessarily need more whizbang technology – it’s about putting the customer experience first.
Color, Verily to Return Actionable Genetic Data to Project Baseline Participants
The Project Baseline Health Study is Verily’s four-year initiative to collect comprehensive health information to better understand health and the transition to disease.
Perspectives on Color
See what customers, physicians, and partners have to say about Color and the difference it’s making in people’s lives.
Physician & Provider Resources
To learn more about ordering Color kits for patients, including requisition and consent forms, sample reports, billing, brochures, and more, visit our provider resources page.
Provider ResourcesColor’s COVID-19 Testing Initiative
For Carla and Kim, two sisters with a history of breast cancer, genetic testing was the final piece of the puzzle explaining why breast cancer has been in their family for three generations.
Lauren doesn’t have a family history of cancer and wouldn’t have gotten tested if it weren’t for her son. Now, she has been able to help her siblings, nieces and nephews get informed.
“We don’t ever want to have to uproot our lives to cancer. If we could have the information at our fingertips, wouldn’t we want it that way?”
LEAP: Using machine learning to support variant classification in a clinical setting
Human Mutation (2020)
Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative
Journal of the National Cancer Institute (2019)
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Nature Communications (2020)
Press Highlights
Color CEO interviewed on CNN regarding employer COVID-19 testing
“Making testing accessible is the context for our work with the city of San Francisco, working with local communities to set up programs so that tests can actually make it to the people who need it the most.”
Color announces $75 million funding round
Fortune Exclusive details $75 million funding round led by T. Rowe Funds and Viking Global Investors.
To Get Back to Work, Companies Seek Coronavirus Tests for Workers
“The core tool we have to work with right now is direct covid testing,” said Othman Laraki, CEO of genetic-testing company Color, which is currently managing a testing site for San Francisco first responders as well as other essential city employees.